{"id":384918,"date":"2020-11-19T08:03:23","date_gmt":"2020-11-19T13:03:23","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=384918"},"modified":"2020-11-19T08:03:23","modified_gmt":"2020-11-19T13:03:23","slug":"aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/","title":{"rendered":"Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p>\n        <em>Investors with losses are encouraged to contact the firm before November 21, 2020; click <\/em><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gNb9-7mpzWj3JnX1jE2zK1Z6J2OD-ivXYzGaEgKDRB3DTckf1hcB7jVckaQQd5_bPMTGZ_LCNGnIs63W2IVexw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n          <em><br \/>\n            <u>here<\/u><br \/>\n          <\/em><br \/>\n        <\/a><br \/>\n        <em> to submit trade information<\/em><br \/>\n        \n      <\/p>\n<p>\u200bLOS ANGELES, Nov.  19, 2020  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WWnqKrLKd96J8V2h04nMuYgOeveBzEv1A855sllWgoSjzD5Cqyr-pBEv7v2bQe20Mjk71yH1vDw476MGMQihDI_EL8ZuLWuRCIuD8EoPi8w=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>The Portnoy Law Firm<\/u><\/a> advises investors that a class action lawsuit has been filed on behalf of Aimmune Therapeutics, Inc. (NASDAQ: AIMT) investors that acquired shares relating to the sale of the Company to Soci\u00e9t\u00e9s des Produits Nestl\u00e9, S.A. Investors have until November 21, 2020 to seek an active role in this litigation.<\/p>\n<p>Investors are encouraged to contact attorney <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=A2ixul_JA3NP-IyW4rmW3s2ERNEdGKGUuMkh0ndzlqLw55HcqGT2UPIz7RjLebMA2jqFP07JCVJgN96UNlL5VqqUXfowi7btbwrTqwAVFDk=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Lesley F. Portnoy<\/u><\/a><u>,<\/u> to determine eligibility to participate in this action, by phone 310-692-8883 or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=acYrKqCcoyeklG24ee-cnKWDGnxgzXp_SetlK1R-BCkg9QyawSpHZ_QydYNM0KosWzS6oGq6ZqmyNJ9BJfVAHuG-AJXsSBTi_5amQFdedtE=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>email<\/u><\/a>, or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Gd_bi2npLNw-zfGJcbqCCDbZnXCoM1S_MvGZgHklV68hc2sqmB2J_URbo0T74YcJrIHZgsvEZiiaXEqi_NOlHQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>click here<\/u><\/a> to join the case.<\/p>\n<p align=\"justify\">It was announced by Aimmune on August 31, 2020 that it had signed an agreement to be acquired by SNP for approximately $2.6 billion. Aimmune stockholders will receive $34.50 in cash for each share of Aimmune common stock owned, pursuant to the merger agreement. The deal is scheduled to be closed in the fourth quarter of 2020.<\/p>\n<p align=\"justify\">It is alleged in the complaint that Aimmune\u2019s board of directors oversaw an unfair process and ultimately agreed to a merger agreement that was inadequate. Aimmune stock has recently traded at a price well above the merger consideration of $34.50.<\/p>\n<p>A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 21, 2020.<\/p>\n<p>Please visit our <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=e9m4pLFfrCwuhfooOJxkCu0p9RofFNnYNlSKXwfueCKQCYvG27hn_XsmZ-sRTbKbJQ-G46RiXLuiIk8gCWtuVA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>website<\/u><\/a> to review more information and submit your transaction information.<\/p>\n<p>The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm\u2019s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>Lesley F. Portnoy, Esq.<br \/>Admitted CA and NY Bar<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sGD860I_zjsfg524lVLx_63XWSAReW9KHQc_9DmRQkWOzJ6hos-A0XYCrwqqC8nhYaSWJW3aiKGxAp7Dm_RlZ4B2B9WK8WrSxfFnkYSOweg=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>lesley@portnoylaw.com<\/u><\/a><br \/>310-692-8883<br \/>www.portnoylaw.com<\/p>\n<p>Attorney Advertising<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODkwNyMzODM0ODg2IzIxOTU1Mjc=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/54559bef-e305-41cc-a45c-4ebe10e9ff5c\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Investors with losses are encouraged to contact the firm before November 21, 2020; click here to submit trade information \u200bLOS ANGELES, Nov. 19, 2020 (GLOBE NEWSWIRE) &#8212; The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Aimmune Therapeutics, Inc. (NASDAQ: AIMT) investors that acquired shares relating to the sale of the Company to Soci\u00e9t\u00e9s des Produits Nestl\u00e9, S.A. Investors have until November 21, 2020 to seek an active role in this litigation. Investors are encouraged to contact attorney Lesley F. Portnoy, to determine eligibility to participate in this action, by phone 310-692-8883 or email, or click here to join the case. It was announced by Aimmune on August 31, 2020 that it &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-384918","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Investors with losses are encouraged to contact the firm before November 21, 2020; click here to submit trade information \u200bLOS ANGELES, Nov. 19, 2020 (GLOBE NEWSWIRE) &#8212; The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Aimmune Therapeutics, Inc. (NASDAQ: AIMT) investors that acquired shares relating to the sale of the Company to Soci\u00e9t\u00e9s des Produits Nestl\u00e9, S.A. Investors have until November 21, 2020 to seek an active role in this litigation. Investors are encouraged to contact attorney Lesley F. Portnoy, to determine eligibility to participate in this action, by phone 310-692-8883 or email, or click here to join the case. It was announced by Aimmune on August 31, 2020 that it &hellip; Continue reading &quot;Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-19T13:03:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODkwNyMzODM0ODg2IzIxOTU1Mjc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm\",\"datePublished\":\"2020-11-19T13:03:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/\"},\"wordCount\":307,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4ODkwNyMzODM0ODg2IzIxOTU1Mjc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/\",\"name\":\"Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4ODkwNyMzODM0ODg2IzIxOTU1Mjc=\",\"datePublished\":\"2020-11-19T13:03:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4ODkwNyMzODM0ODg2IzIxOTU1Mjc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4ODkwNyMzODM0ODg2IzIxOTU1Mjc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/","og_locale":"en_US","og_type":"article","og_title":"Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm - Market Newsdesk","og_description":"Investors with losses are encouraged to contact the firm before November 21, 2020; click here to submit trade information \u200bLOS ANGELES, Nov. 19, 2020 (GLOBE NEWSWIRE) &#8212; The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Aimmune Therapeutics, Inc. (NASDAQ: AIMT) investors that acquired shares relating to the sale of the Company to Soci\u00e9t\u00e9s des Produits Nestl\u00e9, S.A. Investors have until November 21, 2020 to seek an active role in this litigation. Investors are encouraged to contact attorney Lesley F. Portnoy, to determine eligibility to participate in this action, by phone 310-692-8883 or email, or click here to join the case. It was announced by Aimmune on August 31, 2020 that it &hellip; Continue reading \"Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-19T13:03:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODkwNyMzODM0ODg2IzIxOTU1Mjc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm","datePublished":"2020-11-19T13:03:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/"},"wordCount":307,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODkwNyMzODM0ODg2IzIxOTU1Mjc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/","name":"Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODkwNyMzODM0ODg2IzIxOTU1Mjc=","datePublished":"2020-11-19T13:03:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODkwNyMzODM0ODg2IzIxOTU1Mjc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4ODkwNyMzODM0ODg2IzIxOTU1Mjc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aimmune-therapeutics-inc-investors-last-days-to-participate-actively-in-the-class-action-lawsuit-portnoy-law-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aimmune Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/384918","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=384918"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/384918\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=384918"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=384918"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=384918"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}